BOSTON SCIENTIFIC CORPORATION Comprehensive Income
BOSTON SCIENTIFIC CORPORATION (BSX) reported Comprehensive Income of $1.00 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $1.00B, a 870.87% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $1.55B, a 317.20% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $751.00M, a 22.50% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $788.00M, a 345.20% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $2.01B, a 3.17% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $2.08B, a 51.42% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $1.37B, a 95.03% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $704.00M, a 35.77% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00B 10-Q · filed 2026-08-03 | $2.55B 10-Q · filed 2026-08-03 | $3.30B derived: sum of 3 quarters · filed 2026-08-03 | $4.09B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $1.55B 10-Q · filed 2026-05-01 | $2.30B derived: sum of 2 quarters · filed 2026-05-01 | $3.09B derived: sum of 3 quarters · filed 2026-05-01 | $3.19B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $751.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.54B derived: sum of 2 quarters · filed 2026-02-17 | $1.64B derived: sum of 3 quarters · filed 2026-08-03 | $2.01B 10-K · filed 2026-02-17 |
| 2025-09-30 | $788.00M 10-Q · filed 2025-11-03 | $891.00M derived: sum of 2 quarters · filed 2026-08-03 | $1.26B 10-Q · filed 2025-11-03 | $2.23B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $103.00M 10-Q · filed 2026-08-03 | $474.00M 10-Q · filed 2026-08-03 | $1.44B derived: sum of 3 quarters · filed 2026-08-03 | $1.62B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $372.00M 10-Q · filed 2026-05-01 | $1.34B derived: sum of 2 quarters · filed 2026-05-01 | $1.52B derived: sum of 3 quarters · filed 2026-05-01 | $1.87B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $969.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.15B derived: sum of 2 quarters · filed 2026-02-17 | $1.50B derived: sum of 3 quarters · filed 2026-02-17 | $2.08B 10-K · filed 2026-02-17 |
| 2024-09-30 | $177.00M 10-Q · filed 2025-11-03 | $533.00M derived: sum of 2 quarters · filed 2025-11-03 | $1.11B 10-Q · filed 2025-11-03 | $1.45B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $356.00M 10-Q · filed 2025-08-01 | $933.00M 10-Q · filed 2025-08-01 | $1.27B derived: sum of 3 quarters · filed 2026-02-17 | $1.78B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $578.00M 10-Q · filed 2025-05-01 | $916.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.43B derived: sum of 3 quarters · filed 2026-02-17 | $1.73B derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $338.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $849.00M derived: sum of 2 quarters · filed 2026-02-17 | $1.15B derived: sum of 3 quarters · filed 2026-02-17 | $1.37B 10-K · filed 2026-02-17 |
| 2023-09-30 | $511.00M 10-Q · filed 2024-11-01 | $811.00M derived: sum of 2 quarters · filed 2024-11-01 | $1.03B 10-Q · filed 2024-11-01 | $911.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $300.00M 10-Q · filed 2024-08-01 | $523.00M 10-Q · filed 2024-08-01 | $400.00M derived: sum of 3 quarters · filed 2025-02-18 | $687.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $223.00M 10-Q · filed 2024-05-01 | $100.00M derived: sum of 2 quarters · filed 2025-02-18 | $387.00M derived: sum of 3 quarters · filed 2025-02-18 | $858.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$123.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $164.00M derived: sum of 2 quarters · filed 2025-02-18 | $635.00M derived: sum of 3 quarters · filed 2025-02-18 | $704.00M 10-K · filed 2025-02-18 |
| 2022-09-30 | $287.00M 10-Q · filed 2023-11-01 | $758.00M derived: sum of 2 quarters · filed 2023-11-01 | $827.00M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $471.00M 10-Q · filed 2023-08-03 | $540.00M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $69.00M 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $1.10B 10-K · filed 2024-02-20 | |||
| 2010-09-30 | $110.00M 10-Q · filed 2010-11-05 | $189.00M derived: sum of 2 quarters · filed 2010-11-05 | -$1.38B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $79.00M 10-Q · filed 2010-08-05 | -$1.49B 10-Q · filed 2010-08-05 | ||
| 2009-09-30 | -$165.00M 10-Q · filed 2010-11-05 | -$47.00M derived: sum of 2 quarters · filed 2010-11-05 | $11.00M 10-Q · filed 2010-11-05 | |
| 2009-06-30 | $118.00M 10-Q · filed 2010-08-05 | $175.00M 10-Q · filed 2010-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |